Skip to content
FacebookTwitterLinkedinYoutubeInstagram
  • Education and Events
  • News and Updates
  • Partnerships
  • About NFID
  • Support NFID
NFID
  • Infectious Diseases
    • Column 1
      • Chickenpox (Varicella)
      • Chikungunya
      • Coronaviruses (COVID-19)
      • Cytomegalovirus (CMV)
      • Dengue
      • Diphtheria
      • Ebola
      • Flu (Influenza)
      • Hepatitis
      • Hib Disease
    • Column 2
      • HIV/AIDS
      • HPV (Human Papillomavirus)
      • Japanese Encephalitis
      • Measles
      • Meningococcal Disease
      • Mpox
      • Mumps
      • Norovirus
      • Pneumococcal Disease
      • Polio
    • Column 3
      • Rabies
      • Respiratory Syncytial Virus (RSV)
      • Rotavirus
      • Rubella
      • Shingles (Herpes Zoster)
      • Tetanus
      • Tuberculosis (TB)
      • Whooping Cough (Pertussis)
      • Zika
  • Immunization
  • Handwashing
    • Hands In For Handwashing
  • Resources
    • Resource Library
    • En Español
    • Graphics
    • Contagious Chronicles
    • Infectious IDeas (Podcast)
    • Public Service Announcements
    • Real Stories, Real People
    • Surveys and Publications
  • Support NFID
  • Select Language
  • Search

RSV

  1. Home
  2. RSV
  3. Page 4

September 18, 2023

2023 NFID Annual News Conference: Preventing Disease This Fall and Winter

Leading national public health experts will present final 2022-2023 US influenza season data and results from a new national survey of US adults on vaccination behaviors and attitudes around flu, RSV, COVID-19, and pneumococcal disease

Learn More
July 19, 2023

ID News Round-Up

Advances in infectious disease prevention and treatment have made headlines on COVID-19, flu, HPV, RSV, and more

Learn More
June 27, 2023

Schaffner Report: What Adults Should Know about New RSV Vaccines

NFID Medical Director William Schaffner, MD, talks with NFID Executive Director and CEO Marla Dalton, CAE, about new vaccines for RSV

Learn More
June 5, 2023

Expert Insights on Advances in RSV Prevention and Treatment

New tools for the prevention and treatment of respiratory syncytial virus (RSV) are moving through the development pipeline

Learn More
June 1, 2023

Experts to Explore Advances in RSV, COVID-19, and Flu Prevention and Treatment

Annual Conference on Vaccinology Research will feature latest science

Learn More
FAQs & Fact Sheets

Monoclonal Antibodies Fact Sheet (Spanish)

Spanish fact sheet provides information on monoclonal antibodies (mAbs) and the differences between vaccines and mAbs

Learn More
April 25, 2023

NFID Releases Progress Report on Respiratory Syncytial Virus (RSV) Prevention and Treatment

NFID has issued a new report on current efforts and progress in addressing respiratory syncytial virus (RSV) in the US

Learn More
April 14, 2023

ID News Round-Up: Research Breakthroughs and Health Advisories

Read recent news of interest from the world of infectious diseases, with a focus on new research on long COVID; health alerts on Candida auris, dengue fever, and Marburg virus; and vaccines for pneumococcal disease and respiratory syncytial virus (RSV) …

Learn More
Surveys and Publications

Progress Report: Reducing the Burden of RSV across the Lifespan

NFID Progress Report provides updates on advancements in the development of potential interventions and additional disease surveillance, as well as concerning trends in respiratory syncytial virus (RSV) activity in the US in 2022-2023

Learn More

Respiratory Syncytial Virus (RSV)

RSV is a respiratory virus that infects the lungs and breathing passages and can be serious, especially for infants and older adults

Learn More
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next »

Subscribe to NFID Updates

Subscribe
nfid-logo@2x

7201 Wisconsin Avenue
Suite 750
Bethesda, MD 20814
Phone: 301.656.0003

NFID Facebook Profile NFID Twitter Profile NFID LinkedIn Profile NFID Youtube Account Link NFID Instagram Account

1629 K Street, NW
Suite 300
Washington, DC 20006

Founded in 1973, the National Foundation for Infectious Diseases (NFID) is an independent non-profit 501(c)(3) organization dedicated to educating and engaging the public, communities, and healthcare professionals about infectious diseases across the lifespan.

This website is designed to provide education to the public and healthcare professionals about infectious diseases across the lifespan. All information on this site is for general purposes only, is based on US recommendations, and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Contact a qualified healthcare professional if you have questions or concerns about your health.

Federal EIN: 23-7198530

  • Education and Events
  • News and Updates
  • Partnerships
  • About NFID
  • Infectious Diseases
  • Immunization
  • COVID-19
  • Antibiotic Resistance
  • Resources
  • Contact Us
  • Support NFID
  • Privacy Policy
  • Accessibility
  • Disclaimer
Four-Star Rating Badge - Full Color
Platinum Transparency Seal 2023 Candid
vaccine-safety-net
Scroll To Top